This study uses the AirGo band to monitor changes in tidal ventilation in spontaneously breathing patients with COVID-19 associated respiratory failure. It aims to recognize patterns of ventilation associated with worsening respiratory failure in this patient population. If successful, this study will lead to the development of new robust methods for real-time, continuous monitoring of respiratory function in patients with respiratory failure. In turn, such monitoring methods may enable improvements in the medical management of respiratory failure and timing of interventions.
Device: AirGo Respiratory Monitor
AirGo™ is composed of a wearable, miniaturized recorder unit and a medical grade Holter worn over the floating ribs of patients both at rest and during normal activity. The recorder measures live circumference changes.
Inclusion Criteria:
- Admitted to the hospital
- ≥ 18 years of age
- Clinically suspected or confirmed COVID-19 infection
- Spontaneously breathing
- For patients not on supplemental oxygen at their location of residence prior to
hospital admission, need for supplemental O2 to maintain SpO2 >=92%
- For patients on supplemental O2 at their location of residence prior to hospital
admission, an increase in requirement of supplemental oxygen from baseline
Exclusion Criteria:
- Intubated patients
- Pregnant women
- Moribund patients
- Patients who are on comfort measures (CMO)
Massachusetts General Hospital
Boston, Massachusetts, United States
Investigator: Omar Hyder, MD, MS
Contact: 617-724-0151
ohyder@partners.org
Investigator:
Omar Hyder, MD, MS
617-724-0151
ohyder@partners.org
Jeanine Wiener-Kronish, MD
jweiner-kronish@mgh.harvard.edu